Cargando…

Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapy

STUDY OBJECTIVE: To describe characteristics of postmenopausal women on long-term bisphosphonate therapy who fall into one of four fracture risk categories (low, mild, moderate, high), and to determine the prevalence of women eligible for a drug holiday. DESIGN: Retrospective electronic health recor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kostoff, Matthew D, Saseen, Joseph J, Borgelt, Laura M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010634/ https://www.ncbi.nlm.nih.gov/pubmed/24855392 http://dx.doi.org/10.2147/IJWH.S57549

Ejemplares similares

Bisphosphonate drug holidays: Can we recommend currently?
por: Tandon, Vishal R., et al.
Publicado: (2014)

Radiographic changes of mandibular cortical bone in bisphosphonate drug holiday
por: Lee, Dae-Hoon, et al.
Publicado: (2022)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
por: Pazianas, Michael, et al.
Publicado: (2010)

Position Statement: Drug Holiday in Osteoporosis Treatment with Bisphosphonates in South Korea
por: Lee, Seung Hun, et al.
Publicado: (2015)

Comment to “Radiographic changes of mandibular cortical bone in bisphosphonate drug holiday”
por: Vaidyanathan, Aiswarya, et al.
Publicado: (2023)

Increase in the Serum Parathyroid Hormone Level During a Bisphosphonate Drug Holiday
por: Song, Yoon Kyung, et al.
Publicado: (2014)

Bisphosphonate Drug Holidays: Evidence From Clinical Trials and Real‐World Studies
por: Wang, Mawson, et al.
Publicado: (2022)

Can bone turnover markers help to define the suitability and duration of bisphosphonate drug holidays?
por: Statham, Louise, et al.
Publicado: (2020)

Effects of a 'Drug Holiday' on Bone Mineral Density and Bone Turnover Marker During Bisphosphonate Therapy
por: Kong, Sung Yeol, et al.
Publicado: (2013)

Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures — a case report
por: Puah, Ken Lee, et al.
Publicado: (2011)

Role of Bisphosphonates in Postmenopausal Women with Osteoporosis to Prevent Future Fractures: A Literature Review
por: Imam, Bashir, et al.
Publicado: (2019)

Effectiveness of Osteoporosis Drug in Postmenopausal Women with Spinal Compression Fracture: Combined Consecutive Therapy of Teriparatide and Raloxifene versus Bisphosphonate Single
por: Shin, Chang Jin, et al.
Publicado: (2016)

Radiological Factors Associated with Bisphosphonate Treatment Failure and Their Impact on Fracture Healing in Postmenopausal Women with Osteoporotic Vertebral Fractures
por: Kim, Hong Jin, et al.
Publicado: (2023)

Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making
por: Hayes, Kaleen N., et al.
Publicado: (2021)

Skeletal outcomes of patients with osteogenesis imperfecta during drug holiday of bisphosphonates: a real-world study
por: Zhang, Yongze, et al.
Publicado: (2022)

Acute Nontraumatic Clavicle Fracture Associated with Long-Term Bisphosphonate Therapy
por: Vun, Shen Hwa, et al.
Publicado: (2014)

Atypical metatarsal fracture in a patient on long term bisphosphonate therapy
por: Pradhan, Pavan, et al.
Publicado: (2012)

Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy
por: Dózsai, Dávid, et al.
Publicado: (2020)

Women's Holidays
por: Wyndham, Francis M., et al.
Publicado: (1919)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Use of Oral Bisphosphonates in Primary Prevention of Fractures in Postmenopausal Women: A Population-Based Cohort Study
por: Real, Jordi, et al.
Publicado: (2015)

Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
por: Bandeira, Francisco, et al.
Publicado: (2020)

Long term bisphosphonate therapy & atypical femoral fractures: A word of caution
por: Reddy, Sagili Vijaya Bhaskar
Publicado: (2014)

Management of insufficiency fractures associated with long-term bisphosphonate therapy in a cat
por: Meneghetti, Lauren M, et al.
Publicado: (2023)

Women's Holiday Fund
por: London, A. F., et al.
Publicado: (1923)

The effects of teriparatide and bisphosphonates on new fractures in postmenopausal women with osteoporosis: A protocol for systematic review and meta-analysis
por: Ouyang, YuLong, et al.
Publicado: (2021)

Oral bisphosphonate use and lung cancer incidence among postmenopausal women
por: Tao, M H, et al.
Publicado: (2018)

The Effects of Long-term Use of Nitrogen-containing Bisphosphonates on Fracture Healing
por: Begkas, Dimitrios, et al.
Publicado: (2019)

Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial
por: Kim, Jinyoung, et al.
Publicado: (2022)

Bisphosphonate-induced atypical femoral fracture in tandem: long-term follow-up is warranted
por: Hussain, Mohammed Anwar, et al.
Publicado: (2022)

The holidays before the holidays
por: Staff Association
Publicado: (2019)

Holidays and Holiday-Makers
Publicado: (1904)

Bone necrosis around dental implants: A patient treated with oral bisphosphonates, drug holiday and no risk according to serum CTX
por: Flichy-Fernández, A J., et al.
Publicado: (2012)

The effect of drug holiday before tooth extraction on the development of medication-related osteonecrosis of the jaw in cancer patients receiving intravenous bisphosphonates
por: Karaca, Çiğdem, et al.
Publicado: (2023)

Eldecalcitol improves chair-rising time in postmenopausal osteoporotic women treated with bisphosphonates
por: Iwamoto, Jun, et al.
Publicado: (2014)

Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
por: Miller, P. D., et al.
Publicado: (2016)

Bone metabolism genes variation and response to bisphosphonate treatment in women with postmenopausal osteoporosis
por: Marozik, Pavel, et al.
Publicado: (2019)

Patient preference in the management of postmenopausal osteoporosis with bisphosphonates
por: Reginster, Jean-Yves, et al.
Publicado: (2006)

A Case Report of Long-Term Bisphosphonate Therapy and Atypical Stress Fracture of Bilateral Femur
por: Jo, Yil Ryun, et al.
Publicado: (2013)

Long-term use of bisphosphonates in osteoporosis
por: Sadat-Ali, Mir, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8s5nuik4nkehvc856lgj2mvvt6